Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Open in API
Filings indexed 403 across all filing types
Latest filing 2020-09-29 Regulatory Filings
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Brattle Street Investment Corp. It details a material change involving a transformative acquisition, changes in board and management, a proposed name change, share consolidation, and a concurrent financing. The document includes detailed descriptions of the acquisition, management appointments, financing plans, and strategic growth plans. It is a regulatory filing specific to material changes under Canadian securities regulations, not a full annual or quarterly report, earnings release, or proxy statement. It is not a simple announcement or certification but a detailed disclosure of a material corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-29 English
News release - English.pdf
Regulatory Filings
2020-09-17 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Brattle Street Investment Corp. has entered into a debt conversion agreement, issuing shares to satisfy indebtedness. It discusses the transaction details, regulatory approvals, and forward-looking statements. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an update on a financing activity involving capital structure changes (debt converted to equity). It is not an annual or interim report, audit report, or earnings release. It is not a regulatory filing or certification. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes.
2020-09-08 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing Brattle Street Investment Corp.'s strategic focus on medical device investment opportunities and the granting of stock options to directors, officers, and employees. It includes no financial statements, detailed financial performance data, or regulatory filings. The content is primarily an update on capital structure (stock options granted) and investment focus, which aligns with a Capital/Financing Update. The document length is short (2578 characters), and it is not an announcement of a report publication or a certification. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-08-19 English
News release - English.pdf
Regulatory Filings
2020-07-31 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2020-07-30 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.